06:00 AM EDT, 10/21/2025 (MT Newswires) -- Disc Medicine ( IRON ) said Tuesday it priced an upsized offering of its common shares and pre-funded warrants.

The company is selling about 2.6 million shares at $84 apiece and pre-funded warrants to purchase 59,523 shares at $83.9999 per warrant, while AI DMI is selling 297,619 shares.

The gross proceeds from the offering are expected to be $225 million to Disc and $25 million to AI DMI, upsized from the previously planned $200 million and $20 million, respectively.

AI DMI has granted a 30-day overallotment option to the underwriters to acquire up to 446,428 additional shares.

Disc said it plans to use the net proceeds to support the potential commercialization of bitopertin for erythropoietic protoporphyria and X-linked protoporphyria, among other things.

The offering is expected to close Wednesday.

Disc shares were down 1.3% in recent premarket activity.